Turning Point Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

343,133

Value ($000)

25,821

Weight

0.0%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	25,821	0.0%	343,133	6/30/2022
2022 Q1	5/13/2022	9,430	0.0%	351,194	3/31/2022
2021 Q4	2/11/2022	16,447	0.0%	344,795	12/31/2021
2021 Q3	11/16/2021	22,362	0.0%	336,610	9/30/2021
2021 Q2	8/16/2021	24,943	0.0%	319,694	6/30/2021
2021 Q1	5/17/2021	27,737	0.0%	293,227	3/31/2021
2020 Q4	2/16/2021	32,808	0.0%	269,243	12/31/2020
2020 Q3	11/13/2020	20,515	0.0%	234,822	9/30/2020
2020 Q2	8/20/2020	9,642	0.0%	149,268	6/30/2020
2020 Q1	5/15/2020	5,265	0.0%	117,890	3/31/2020
2019 Q4	2/7/2020	7,243	0.0%	116,265	12/31/2019